- Report
- May 2022
- 843 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- May 2022
- 75 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Report
- May 2022
- 81 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Report
- March 2025
- 211 Pages
China
From €3641EUR$4,000USD£3,092GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1320EUR$1,450USD£1,121GBP
- Report
- October 2024
Global
From €3186EUR$3,500USD£2,706GBP
- Report
- March 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- March 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- March 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- March 2022
Japan, United States, ... Japan, United States, Europe
From €1320EUR$1,450USD£1,121GBP
- Report
- October 2023
- 230 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- February 2022
- 215 Pages
Global
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP
- Book
- February 2024
- 592 Pages
- Book
- June 2020
- 402 Pages

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression.
Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more